Byrn, INC

Market Movers (8-K)

OTC.Pink
BRYN INC. announced a significant change in control with MEDO Healthcare LLC acquiring a majority voting stake, leading to a transition in leadership.

Quarterly Earnings (10-Q)

OTC.Pink
Bryn Inc. reports Q1 2026 results with significant management changes and a planned pivot to acquiring pharmaceutical distributors, aiming to leverage AI technology.
Capital raise
Worse than expected
OTC.Pink
BYRN INC., a dormant shell company, reported continued operating losses in Q3 2025 and is actively seeking a reverse merger to acquire an operating business, facing significant financial and operational challenges.
Capital raise
Worse than expected
OTC.Pink
BYRN INC. reported a net loss of $24,882 for the six months ended June 30, 2025, with no revenue and significant internal control weaknesses, as it continues to operate as a dormant shell company seeking a reverse merger.
Worse than expected
Capital raise
OTC.Pink
Byrn Inc. reported no revenue and a net loss of $16,410 for the quarter ended March 31, 2025, as it continues to seek a business opportunity through a reverse merger.
Worse than expected
Capital raise
OTC.Pink
Byrn Inc.'s latest quarterly report reveals ongoing operating losses and a continued search for potential business combinations to revitalize the company.
Worse than expected
Capital raise
OTC.Pink
Born, Inc. reported continued financial losses and operational inactivity for the second quarter ended June 30, 2024, as it seeks a business combination to resume operations.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Byrn, Inc. remains a dormant shell company with no operations or revenue, reporting a net loss of $40,025 for 2025.
Capital raise
OTC.Pink
Byrn Inc., a dormant shell company, filed its annual report on Form 10-K, outlining its current state and future plans to explore potential business opportunities.
Capital raise
Worse than expected
OTC.Pink
Born, Inc., a dormant shell company, files its annual report on Form 10-K, highlighting its financial status and future plans to explore business opportunities.
Worse than expected
Capital raise
OTC.Pink
Born, Inc.'s 2022 10-K filing reveals the company remains a dormant shell, actively seeking a reverse merger or acquisition to revitalize its operations.
Worse than expected
Capital raise
OTC.Pink
Born, Inc.'s 2021 10-K filing indicates the company remains a dormant shell, actively seeking a viable business opportunity, including a potential reverse merger.
Worse than expected
Capital raise
OTC.Pink
Born Inc. amends its 2020 annual report to reflect a change in auditors and restated financials, including a significant gain on debt extinguishment.
Worse than expected